BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8875985)

  • 1. Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene.
    Coppée F; Gérard AC; Denef JF; Ledent C; Vassart G; Dumont JE; Parmentier M
    Oncogene; 1996 Oct; 13(7):1471-82. PubMed ID: 8875985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transgenic mouse models. Their interest in thyroid tumors].
    Ledent C; Franc B; Parmentier M
    Arch Anat Cytol Pathol; 1998; 46(1-2):31-7. PubMed ID: 9754358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene.
    Ledent C; Marcotte A; Dumont JE; Vassart G; Parmentier M
    Oncogene; 1995 May; 10(9):1789-97. PubMed ID: 7753555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic models for proliferative and hyperfunctional thyroid diseases.
    Ledent C; Coppée F; Dumont JE; Vassart G; Parmentier M
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 3():43-6. PubMed ID: 8986422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transgenic models of human thyroid pathologies: hyperfunctional adenoma, anaplastic cancer, differentiated cancer, hypothyroidism].
    Ledent C
    Bull Mem Acad R Med Belg; 1996; 151(2):195-201. PubMed ID: 9004925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papilloma virus 16 E7 oncogene does not cooperate with RET/PTC 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice.
    Portella G; Borselli C; Santoro M; Gerbasio D; D'Armiento MR; Dumont JE; Ledent C; Rothstein JL; Vecchio G; Fusco A
    Oncol Res; 2001; 12(8):347-54. PubMed ID: 11589306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers.
    Burniat A; Jin L; Detours V; Driessens N; Goffard JC; Santoro M; Rothstein J; Dumont JE; Miot F; Corvilain B
    Endocrinology; 2008 Oct; 149(10):5107-17. PubMed ID: 18583418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human papillomavirus type 16 E7 protein as a model antigen to study the vaccine potential in control and E7 transgenic mice.
    Gérard CM; Baudson N; Kraemer K; Ledent C; Pardoll D; Bruck C
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):838s-847s. PubMed ID: 11300481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
    Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
    Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
    Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
    Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes.
    Carraresi L; Tripodi SA; Mulder LC; Bertini S; Nuti S; Schuerfeld K; Cintorino M; Bensi G; Rossini M; Mora M
    Oncogene; 2001 Dec; 20(56):8148-53. PubMed ID: 11781829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
    Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
    Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter.
    Rochefort P; Caillou B; Michiels FM; Ledent C; Talbot M; Schlumberger M; Lavelle F; Monier R; Feunteun J
    Oncogene; 1996 Jan; 12(1):111-8. PubMed ID: 8552381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple genetic loci modify risk for retinoblastoma in transgenic mice.
    Griep AE; Krawcek J; Lee D; Liem A; Albert DM; Carabeo R; Drinkwater N; McCall M; Sattler C; Lasudry JG; Lambert PF
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2723-32. PubMed ID: 9856783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes.
    Doan T; Chambers M; Street M; Fernando GJ; Herd K; Lambert P; Tindle R
    Virology; 1998 May; 244(2):352-64. PubMed ID: 9601506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models of thyroid goiter and tumors in transgenic mice.
    Ledent C; Parmentier M; Vassart G; Dumont JE
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):167-9. PubMed ID: 8056152
    [No Abstract]   [Full Text] [Related]  

  • 17. A human papillomavirus type 18 E6/E7 transgene sensitizes mouse lens cells to human wild-type p53-mediated apoptosis.
    Nakamura T; Williams-Simons L; Westphal H
    Oncogene; 1997 Jun; 14(25):2991-8. PubMed ID: 9223662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein.
    Herd K; Fernando GJ; Dunn LA; Frazer IH; Lambert P; Tindle RW
    Virology; 1997 Apr; 231(1):155-65. PubMed ID: 9143315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.
    Schaper ID; Marcuzzi GP; Weissenborn SJ; Kasper HU; Dries V; Smyth N; Fuchs P; Pfister H
    Cancer Res; 2005 Feb; 65(4):1394-400. PubMed ID: 15735026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter.
    Santelli G; de Franciscis V; Portella G; Chiappetta G; D'Alessio A; Califano D; Rosati R; Mineo A; Monaco C; Manzo G
    Cancer Res; 1993 Nov; 53(22):5523-7. PubMed ID: 8221693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.